These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23906381)

  • 21. [Molecular characterization of complex recombinant HIV-1 CRF06_cpx subtype detected in Turkey].
    Sayan M; Kaptan F; Ormen B; Türker N
    Mikrobiyol Bul; 2014 Jan; 48(1):160-7. PubMed ID: 24506727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology of HIV type 1 in Mexico: emergence of BG and BF intersubtype recombinants.
    Vázquez-Valls E; Escoto-Delgadillo M; López-Márquez FC; Castillero-Manzano M; Echegaray-Guerrero E; Bitzer-Quintero OK; Kobayashi-Gutiérrez A; Torres-Mendoza BM
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):777-81. PubMed ID: 20624071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short communication: Molecular characterization of HIV type 1 BF pol recombinants from São Paulo, Brazil.
    de Souza AC; de Oliveira CM; Rodrigues CL; Silva SA; Levi JE
    AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1521-5. PubMed ID: 19025398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians.
    Tsegaye A; Ran L; Wolday D; Petros B; Nanlohy NM; Meles H; Girma M; Hailu E; Borghans J; Miedema F; van Baarle D
    AIDS; 2007 Jan; 21(3):369-72. PubMed ID: 17255746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000-2014.
    Castley AS; Gaudieri S; James I; Gizzarelli LS; Guelfi G; John M; Nolan D
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):211-9. PubMed ID: 26530340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).
    Yebra G; Rivas P; Herrero MD; López M; de Mulder M; Puente S; Ramírez-Olivencia G; Soriano V; Holguín A
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):37-44. PubMed ID: 19182919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count.
    Kupfer B; Kaiser R; Rockstroh JK; Matz B; Schneweis KE
    J Med Virol; 1998 Nov; 56(3):259-63. PubMed ID: 9783695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low levels of HIV-1 plasma viral load in patients infected with HIV-1 subtype b and advanced immunosuppression.
    de la Rosa R; Leal M; Pineda JA; Dietrich U; Delgado J; Macías J; Rubio A; Sánchez-Quijano A; Lissen E
    J Infect; 2001 Jan; 42(1):4-7. PubMed ID: 11243746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda.
    Lee GQ; Lachowski C; Cai E; Lima VD; Boum Y; Muzoora C; Mocello AR; Hunt PW; Martin JN; Bangsberg DR; Harrigan PR
    AIDS; 2016 Jul; 30(11):1781-8. PubMed ID: 27124899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between HIV genotype, viral load and disease progression in a cohort of Thai men who have sex with men with estimated dates of HIV infection.
    Leelawiwat W; Pattanasin S; Sriporn A; Wasinrapee P; Kongpechsatit O; Mueanpai F; Tongtoyai J; Holtz TH; Curlin ME
    PLoS One; 2018; 13(7):e0201386. PubMed ID: 30063722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India.
    Ding M; Tarwater P; Rodriguez M; Chatterjee R; Ratner D; Yamamura Y; Roy P; Mellors J; Neogi D; Chen Y; Gupta P
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):119-25. PubMed ID: 19131898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
    Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
    J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.
    Kiwanuka N; Robb M; Laeyendecker O; Kigozi G; Wabwire-Mangen F; Makumbi FE; Nalugoda F; Kagaayi J; Eller M; Eller LA; Serwadda D; Sewankambo NK; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Whalen CC
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):180-4. PubMed ID: 20010433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.
    Kiwanuka N; Laeyendecker O; Robb M; Kigozi G; Arroyo M; McCutchan F; Eller LA; Eller M; Makumbi F; Birx D; Wabwire-Mangen F; Serwadda D; Sewankambo NK; Quinn TC; Wawer M; Gray R
    J Infect Dis; 2008 Mar; 197(5):707-13. PubMed ID: 18266607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of high-level resistance mutations in HIV type 1 BF recombinant strains circulating in northeast Brazil.
    Monteiro-Cunha JP; Araujo AF; Santos E; Galvao-Castro B; Alcantara LC
    AIDS Res Hum Retroviruses; 2011 Jun; 27(6):623-31. PubMed ID: 21087197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.